Induction of multidrug tolerance in Plasmodium falciparum by extended artemisinin pressure

Emerging Infectious Diseases

Volumn 21, Issue 10, 2015, Pages 1733-1741

  Ménard, Sandie ^a,b   Haddou, Tanila Ben ^a,c   Ramadani, Arba Pramundita ^a,c,f   Ariey, Frédéric ^d   Iriart, Xavier ^a,b,e   Beghain, Johann ^d   Bouchier, Christiane ^d   Witkowski, Benoit ^a,c,g   Berry, Antoine ^a,b,e   Mercereau Puijalon, Odile ^d   Benoit Vical, Françoise ^a,c  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b University of Toulouse III   (France)

^c CNRS   (France)

^d INSTITUT PASTEUR   (France)

^e TOULOUSE UNIVERSITY HOSPITAL   (France)

^f GADJAH MADA UNIVERSITY   (Indonesia)

^g INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMETHER; ARTEMISININ; ARTEMISONE; ARTESUNATE; ATOVAQUONE; CHLOROQUINE; DIHYDROARTEMISININ; ENDOPEROXIDE; FOLIC ACID ANTAGONIST; MEFLOQUINE; PYRIMETHAMINE; QUININE; QUINOLONE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; ASSAY; CELL PROLIFERATION; CHEMOSENSITIVITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RECRUDESCENCE ASSAY; DRUG TOLERANCE; GENE SEQUENCE; GENETIC ASSOCIATION; INHIBITORY CONCENTRATION; MALARIA; MALARIA CONTROL; METABOLISM; NONHUMAN; PARASITE CLEARANCE; PARASITE SURVIVAL; PARASITEMIA; PLASMODIUM FALCIPARUM; RING STAGE GROWTH ARREST ASSAY; RING STAGE SURVIVAL ASSAY; TROPHOZOITE; DRUG EFFECTS; HUMAN; IMMUNOLOGY; MALARIA, FALCIPARUM; PARASITOLOGY; SOUTHEAST ASIA;

ANTIMALARIALS; ARTEMISININS; ASIA, SOUTHEASTERN; DRUG TOLERANCE; HUMANS; MALARIA; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

EID: 84942082243     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2110.150682     Document Type: Article

References (35)

1. World Health Organization. World malaria report, 2014. Geneva: The Organization; 2014.
2. World Health Organization Global Malaria Programme. Status report on artemisinin resistance. WHO/HTM/GMP/20149, 2014. Geneva: The Organization; 2014.
3. Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, et al. Independent emergence of Plasmodium falciparum artemisinin resistance mutations in Southeast Asia. J Infect Dis. 2015;211:670-9. http://dx.doi.org/10.1093/infdis/ jiu491
4. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411-23. http://dx.doi.org/10.1056/NEJMoa1314981
5. Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis. 2015;15:415-21. http://dx.doi.org/10.1016/ S1473-3099(15)70032-0
6. Miotto O, Amato R, Ashley EA, MacInnis B, Almagro-Garcia J, Amaratunga C, et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet. 2015;47:226-34. http://dx.doi.org/10.1038/ng.3189
7. Borrmann S, Sasi P, Mwai L, Bashraheil M, Abdallah A, Muriithi S, et al. Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast. PLoS ONE. 2011;6:e26005. http://dx.doi.org/ 10.1371/journal.pone.0026005
8. Vreden SG, Jitan JK, Bansie RD, Adhin MR. Evidence of an increased incidence of day 3 parasitaemia in Suriname: an indicator of the emerging resistance of Plasmodium falciparum to artemether. Mem Inst Oswaldo Cruz. 2013;108:968-73. http://dx.doi.org/10.1590/0074-0276130167
9. Witkowski B, Lelievre J, Barragan MJ, Laurent V, Su XZ, Berry A, et al. Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism. Antimicrob Agents Chemother. 2010;54:1872-7. http://dx.doi.org/10.1128/ AAC.01636-09
10. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin resistant Plasmodium falciparum malaria. Nature. 2014;505:50-5. http://dx.doi.org/10.1038/nature12876
11. Witkowski B, Khim N, Chim P, Kim S, Ke S, Kloeung N, et al. Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia. Antimicrob Agents Chemother. 2013;57:914-23. http://dx.doi.org/10.1128/AAC.01868-12
12. Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, et al. Novel phenotypic assays for the detection of artemisininresistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect Dis. 2013;13:1043-9. http://dx.doi.org/10.1016/S1473-3099(13)70252-4
13. Straimer J, Gnadig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, et al. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 2015;347:428-31. http://dx.doi.org/10.1126/science.1260867
14. Amaratunga C, Witkowski B, Dek D, Try V, Khim N, Miotto O, et al. Plasmodium falciparum founder populations in western Cambodia have reduced artemisinin sensitivity in vitro. Antimicrob Agents Chemother. 2014;58:4935-7. http://dx.doi.org/ 10.1128/AAC.03055-14
15. Amaratunga C, Witkowski B, Khim N, Menard D, Fairhurst RM. Artemisinin resistance in Plasmodium falciparum. Lancet Infect Dis. 2014;14:449-50. http://dx.doi.org/10.1016/ S1473-3099(14)70777-7
16. Lewis K. Persister cells. Annu Rev Microbiol. 2010;64:357-72. http://dx.doi.org/10.1146/annurev.micro.112408.134306
17. Wolfson JS, Hooper DC, Mchugh GL, Bozza MA, Swartz MN. Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and β-lactam antimicrobial agents. Antimicrob Agents Chemother. 1990;34:1938-43. http://dx.doi.org/10.1128/ AAC.34.10.1938
18. Moyed HS, Bertrand KP. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol. 1983;155:768-75.
19. Witkowski B, Lelievre J, Nicolau-Travers ML, Iriart X, Njomnang Soh P, Bousejra-Elgarah F, et al. Evidence for the contribution of the hemozoin synthesis pathway of the murine Plasmodium yoelii to the resistance to artemisinin-related drugs. PLoS ONE. 2012;7:e32620. http://dx.doi.org/10.1371/ journal.pone.0032620
20. Benoit-Vical F, Lelievre J, Berry A, Deymier C, Dechy-Cabaret O, Cazelles J, et al. Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes. Antimicrob Agents Chemother. 2007;51:1463-72. http://dx.doi.org/10.1128/ AAC.00967-06
21. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979;16:710-8. http://dx.doi.org/10.1128/AAC.16.6.710
22. Dawson CC, Intapa C, Jabra-Rizk MA. "Persisters": survival at the cellular level. PLoS Pathog. 2011;7:e1002121. http://dx.doi.org/10.1371/journal.ppat.1002121
23. Chen N, LaCrue AN, Teuscher F, Waters NC, Gatton ML, Kyle DE, et al. Fatty acid synthesis and pyruvate metabolism pathways remain active in dihydroartemisinin-induced dormant ring stages of Plasmodium falciparum. Antimicrob Agents Chemother. 2014;58:4773-81. http://dx.doi.org/10.1128/AAC.02647-14
24. Mok S, Ashley EA, Ferreira PE, Zhu L, Lin Z, Yeo T, et al. Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance. Science. 2015;347:431-5. http://dx.doi.org/10.1126/ science.1260403
25. Veiga MI, Ferreira PE, Schmidt BA, Ribacke U, Bjorkman A, Tichopad A, et al. Antimalarial exposure delays Plasmodium falciparum intra-erythrocytic cycle and drives drug transporter genes expression. PLoS ONE. 2010;5:e12408. http://dx.doi.org/ 10.1371/journal.pone.0012408
26. Bohórquez EB, Juliano JJ, Kim HS, Meshnick SR. Mefloquine exposure induces cell cycle delay and reveals stage-specific expression of the pfmdr1 gene. Antimicrob Agents Chemother. 2013;57:833-9. http://dx.doi.org/10.1128/AAC.01006-12
27. Peatey CL, Chavchich M, Chen N, Gresty KJ, Gray KA, Gatton ML, et al. Mitochondrial membrane potential in a small subset of artemisinin-induced dormant Plasmodium falciparum parasites in vitro. J Infect Dis. 2015;212:426-34. http://dx.doi.org/ 10.1093/infdis/jiv048
28. Sijwali PS, Rosenthal PJ. Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum. Proc Natl Acad Sci U S A. 2004;101:4384-9. http://dx.doi.org/10.1073/pnas.0307720101
29. Klonis N, Crespo-Ortiz MP, Bottova I, Abu-Bakar N, Kenny S, Rosenthal PJ, et al. Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion. Proc Natl Acad Sci U S A. 2011;108:11405-10. http://dx.doi.org/10.1073/pnas.1104063108
30. Foley M, Tilley L. Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol Ther. 1998;79:55-87. http://dx.doi.org/10.1016/S0163-7258(98)00012-6
31. Robert A, Benoit-Vical F, Claparols C, Meunier B. The antimalarial drug artemisinin alkylates heme in infected mice. Proc Natl Acad Sci U S A. 2005;102:13676-80. http://dx.doi.org/ 10.1073/pnas.0500972102
32. Conrad MD, Bigira V, Kapisi J, Muhindo M, Kamya MR, Havlir DV, et al. Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children. PLoS ONE. 2014;9:e105690. http://dx.doi.org/10.1371/ journal.pone.0105690
33. Nyunt MH, Hlaing T, Oo HW, Tin-Oo LL, Phway HP, Wang B, et al. Molecular assessment of artemisinin resistance markers, polymorphisms in the K13 propeller, and a multidrug-resistance gene in the eastern and western border areas of Myanmar. Clin Infect Dis. 2015;60:1208-15. http://dx.doi.org/10.1093/cid/ciu1160
34. Kamau E, Campino S, Amenga-Etego L, Drury E, Ishengoma D, Johnson K, et al. K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa. J Infect Dis. 2015;211:1352-5.
35. Saunders DL, Vanachayangkul P, Lon C. Dihydroartemisininpiperaquine failure in Cambodia. N Engl J Med. 2014;371:484-5. http://dx.doi.org/10.1056/NEJMc1403007